These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1361141)

  • 1. Toxicokinetics of colchicine in humans: analysis of tissue, plasma and urine data in ten cases.
    Rochdi M; Sabouraud A; Baud FJ; Bismuth C; Scherrmann JM
    Hum Exp Toxicol; 1992 Nov; 11(6):510-6. PubMed ID: 1361141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
    Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
    Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics/bioavailability of colchicine in healthy male volunteers.
    Achtert G; Scherrmann JM; Christen MO
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):317-22. PubMed ID: 2633927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine poisoning: report of a fatal case with body fluid and post-mortem tissue analysis by high-performance liquid chromatography.
    Dehon B; Chagnon JL; Vinner E; Pommery J; Mathieu D; Lhermitte M
    Biomed Chromatogr; 1999 May; 13(3):235-8. PubMed ID: 10375125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine disposition in patients with familial Mediterranean fever with renal impairment.
    Ben-Chetrit E; Scherrmann JM; Zylber-Katz E; Levy M
    J Rheumatol; 1994 Apr; 21(4):710-3. PubMed ID: 8035398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
    Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
    Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine kinetics in patients with familial Mediterranean fever.
    Halkin H; Dany S; Greenwald M; Shnaps Y; Tirosh M
    Clin Pharmacol Ther; 1980 Jul; 28(1):82-7. PubMed ID: 7389258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of thiocolchicoside in humans using a specific radioimmunoassay.
    Sandouk P; Chappey O; d'Yvoire MB; Scherrmann JM
    Ther Drug Monit; 1995 Oct; 17(5):544-8. PubMed ID: 8585121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fab-bound colchicine appears to adopt Fab fragment disposition in rats.
    Sabouraud AE; Urtizberea M; Benmoussa K; Cano NJ; Scherrmann JM
    J Pharm Pharmacol; 1992 Dec; 44(12):1015-9. PubMed ID: 1361548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dosing adjustments required for colchicine in the elderly compared with younger patients?
    Wason S; Faulkner RD; Davis MW
    Adv Ther; 2012 Jun; 29(6):551-61. PubMed ID: 22753019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of colchicine: a review of experimental and clinical data.
    Sabouraud A; Rochdi M; Urtizberea M; Christen MO; Achtert G; Scherrmann JM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():35-9. PubMed ID: 1449014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of goat colchicine specific antibodies on murine colchicine disposition.
    Terrien N; Urtizberea M; Scherrmann JM
    Toxicology; 1989 Nov; 59(1):11-22. PubMed ID: 2815097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-independent pharmacokinetics of colchicine after oral administration to healthy volunteers.
    Girre C; Thomas G; Scherrmann JM; Crouzette J; Fournier PE
    Fundam Clin Pharmacol; 1989; 3(5):537-43. PubMed ID: 2606428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats.
    Bittner B; González RC; Walter I; Kapps M; Huwyler J
    Biopharm Drug Dispos; 2003 May; 24(4):173-81. PubMed ID: 12698501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine clearance is impaired in alcoholic cirrhosis.
    Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
    Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
    Weinling E; Sandouk P; Debray M; Scherrmann JM
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatment.
    Rudi J; Raedsch R; Gerteis C; Schlenker T; Plachky J; Walter-Sack I; Sabouraud A; Scherrmann JM; Kommerell B
    Scand J Gastroenterol; 1994 Apr; 29(4):346-51. PubMed ID: 8047810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colchicine: recent data on pharmacokinetics and clinical pharmacology].
    Chappey O; Scherrmann JM
    Rev Med Interne; 1995; 16(10):782-9. PubMed ID: 8525161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine poisoning: case report of two suicides.
    Deveaux M; Hubert N; Demarly C
    Forensic Sci Int; 2004 Jul; 143(2-3):219-22. PubMed ID: 15240048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.